Company Profile
Company Overview
ABOUT BRAINTREE, A PART OF SEBELA PHARMACEUTICALS INC.
Braintree is the GI division of Sebela Pharmaceuticals, a leading specialty pharmaceutical company focused on three core therapeutic areas: gastroenterology, dermatology and women’s health. As part of Sebela, Braintree is a market leader in GI, including the #1 prescribed, branded bowel prep product, SUPREP and five marketed GI products as well as a rich near-term GI pipeline of products for diarrhea, constipation, and next generation colonoscopy preps providing multiple product launches over the next three to four years.
Sebela’s growth is driven by our management team and employees through targeted product promotion in our core specialties, judicious investment in research and development and pursuit of our acquisition strategy. Our culture is characterized by a high degree of urgency, open dialogue and discussion across all levels of the team, willingness to challenge the “traditional” approach, and shared ownership of the organization we’re building and our results. We operate with a lean approach, focusing on investments that drive the growth of our business. We are all willing to step in and do whatever is needed on any given day, regardless of the title we hold. Sebela offers a competitive compensation package including base salary, bonus based on personal and company performance, options (both upon hiring and potential in future years based on performance), and a comprehensive health benefits package.
Company History
Sebela Pharmaceuticals Inc. was founded in 2013 in Roswell, Georgia. We have grown over the years both organically and through acquisitions in the therapeutic areas of Gastroenterology, Dermatology and Women's Health. We have locations in Braintree, Holbrook and Randolph, MA, and in Dublin, Ireland. We also have a field salesforce and remote team members all over the US.